Moderna just finished recruiting 30,000 people for its coronavirus vaccine trial. One graph reveals how the biotech slowed down its research to recruit more minorities.
Minorities make up 37% of the study, but that percentage was on track to be much lower until the company slowed enrollment and closed trial sites.
Full Article
